BIOTRONIK Blog

BIOTRONIK, a global leader in medical technology, today announced a strategic distribution agreement with CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias. BIOTRONIK will serve as the exclusive distributor of the Centauri™ Pulsed Field Ablation (PFA) System in selected European countries. This collaboration represents a significant milestone in the commercial expansion of Centauri — a next generation focal PFA system that provides physicians with highly controllable and versatile solution for cardiac ablation in the treatment of

For the third year in a row, BIOTRONIK has been named “Supplier of the Year” in the category Medical by Prospitalia. This hattrick sets a new benchmark and distinction that no other company has ever achieved in the Medtech field. As a company, we are honored by the trust and recognition from our clinical partners. The Prospitalia Supplier Award emphasizes BIOTRONIK’s unwavering commitment to quality, reliability, and customer-centric service in a highly competitive market. The award, presented during the Prospitalia Congress 2025 in Frankfurt, recognizes outstanding performance across key

BIOTRONIK, a global leader in medical technology, and a pioneer in cardiovascular, endovascular, and neuromodulation solutions, today announced a strategic shift to strengthen its leadership in active implantable devices and digital healthcare. Leveraging future technologies, including artificial intelligence (AI), remote patient monitoring and connected healthcare platforms, BIOTRONIK is at the forefront of improving patient outcomes and optimizing clinical workflows. These innovations are designed to enhance the efficiency and accessibility of care, enabling healthcare providers with next